Simulation of the optimal control P2 using <i>ω</i>₁ = 1, <i>ω</i>₂ = .5 and <i>u</i>_<i>max</i> = 10. by Maria C. A. Leite (5586701)

DNase I overexpression reduced <i>A3A</i> upregulation upon MeV infection. by Pierre Khalfi (7868252)

Subjects:

AnxA5 results in a tendency to decrease the monocyte endothelium interaction in a flow model. by Robert Stöhr (3583700)

CPSF6 protein expression is decreased in virus-infected cells. by Yong Ge (816832)

DPT3 Stat EDHS for five surveys. by Hailu Fekadu (17797638)

“…However, based on the subnational region level, significance difference (PAR) was found in all surveys: 59.7 (2000), 51.1 (2005), 52.2 (2011), 42.5 (2016) and 30.7 (2019). The interesting point of this finding was that, the value of absolute inequality measures (PAR) and (PAF), are shown a decreasing trends from 2000 to 2019, and the gap among the better of regions and poor regions becoming narrowed over the last 20 years. …”

FEA results meshes for 5N force. by Nathan L. Wright (18389458)

Data_Sheet_1_Early decrease of ventilatory ratio after prone position ventilation may predict successful weaning in patients with acute respiratory distress syndrome: A retrospecti... by Zhichang Wang (2560528)

“…VR responders were defined as patients showing a decrease in VR of greater than or equal to 0.037 from the baseline to within 4 h after prone. …”

General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

Residuals of the seven evaluated fitting equations. by Kai Roecker (847195)

Mean ± SD values for the parameters found when Eq. 8 (S1 Appendix) was used to model the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and the weig... by Kai Roecker (847195)

The distribution of variables in PCR+ participants with detectable antibodies grouped as decreased, unchanged, increased, and antibody level ≥ 10 at time point T1 and T2. by Marjut Sarjomaa (13229272)

“…<p>The distribution of variables in PCR+ participants with detectable antibodies grouped as decreased, unchanged, increased, and antibody level ≥ 10 at time point T1 and T2.…”

<i>HSpeed</i> results overview. by Kai Roecker (847195)

Graphical description of the fitting parameters. by Kai Roecker (847195)

Mean ± SD values for the parameters found with fittings of Eq. 8, S1 Appendix) to the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and maximum hor... by Kai Roecker (847195)

Groups of power-profile curve fittings. by Kai Roecker (847195)

Independence of the lower against the upper asymptotes. by Kai Roecker (847195)

Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey by Rujipat Wasitthankasem (732723)

Possible Points of Canonical Wnt Inhibition. by Laura Corbett (826084)

The shortened version of the Edinburgh Handedness Inventory encompasses 4 items (e.g. writing) scored on a 5-point scale ranging from:” Always right; usually right; both equally; u... by Marcel F. Hinss (14675457)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”